Knight Therapeutics Stock Analysis
| GUD Stock | CAD 6.00 0.05 0.83% |
Knight Therapeutics is fairly valued with Real Value of 5.97 and Hype Value of 5.99. The main objective of Knight Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Knight Therapeutics is worth, separate from its market price. There are two main types of Knight Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Knight Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Knight Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Knight Therapeutics stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Knight Therapeutics is usually not traded on Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day. Knight Stock trading window is adjusted to America/Toronto timezone.
Knight |
Knight Stock Analysis Notes
About 46.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.76. Some equities with similar Price to Book (P/B) outperform the market in the long run. Knight Therapeutics has Price/Earnings (P/E) ratio of 133.9. The entity had not issued any dividends in recent years. Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally. The company was incorporated in 2013 and is headquartered in Montreal, Canada. KNIGHT THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. To learn more about Knight Therapeutics call Jonathan Goodman at 514-484-4483 or check out https://www.knighttx.com.Knight Therapeutics Quarterly Total Revenue |
|
Knight Therapeutics Investment Alerts
| About 46.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Advanced Trading Insights - news.stocktradersdaily.com |
Knight Largest EPS Surprises
Earnings surprises can significantly impact Knight Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-10 | 2023-06-30 | 0.03 | 0.02 | -0.01 | 33 | ||
2022-08-11 | 2022-06-30 | 0.08 | 0.09 | 0.01 | 12 | ||
2021-05-14 | 2021-03-31 | 0.04 | 0.05 | 0.01 | 25 |
Knight Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 602.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Knight Therapeutics's market, we take the total number of its shares issued and multiply it by Knight Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Knight Profitablity
Knight Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Knight Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Knight Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Knight Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Knight Therapeutics' profitability requires more research than a typical breakdown of Knight Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Management Efficiency
As of the 22nd of July 2025, Return On Capital Employed is likely to grow to 0.01, while Return On Tangible Assets are likely to drop 0.01. At this time, Knight Therapeutics' Total Current Assets are very stable compared to the past year. As of the 22nd of July 2025, Intangibles To Total Assets is likely to grow to 0.40, while Total Assets are likely to drop about 961.1 M. Knight Therapeutics' management efficiency ratios could be used to measure how well Knight Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 7.87 | 7.93 | |
| Tangible Book Value Per Share | 4.21 | 6.12 | |
| Enterprise Value Over EBITDA | 7.90 | 8.30 | |
| Price Book Value Ratio | 0.68 | 1.06 | |
| Enterprise Value Multiple | 7.90 | 8.30 | |
| Price Fair Value | 0.68 | 1.06 | |
| Enterprise Value | 508.9 M | 461.2 M |
Leadership effectiveness at Knight Therapeutics is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 22nd of July, Knight Therapeutics secures the Downside Deviation of 1.47, mean deviation of 0.886, and Risk Adjusted Performance of 0.0594. Knight Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Knight Therapeutics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Knight Therapeutics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Knight Therapeutics short-term fluctuations and highlight longer-term trends or cycles.
Knight Therapeutics Predictive Daily Indicators
Knight Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Knight Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 901.28 | |||
| Daily Balance Of Power | (0.38) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 6.07 | |||
| Day Typical Price | 6.04 | |||
| Price Action Indicator | (0.09) | |||
| Period Momentum Indicator | (0.05) |
Knight Therapeutics Forecast Models
Knight Therapeutics' time-series forecasting models are one of many Knight Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Knight Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Knight Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Knight Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Knight shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Knight Therapeutics. By using and applying Knight Stock analysis, traders can create a robust methodology for identifying Knight entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.01 | 0.01 | |
| Operating Profit Margin | 0.02 | 0.02 | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.47 | 0.64 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Knight Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.